. Author manuscript; available in PMC: 2021 Dec 1.

Published in final edited form as: Curr Microbiol. 2020 Oct 13;77(12):4029–4036. doi: 10.1007/s00284-020-02242-6

Table 1:

General features of the clinical strains included in the study.

Strain	Specie	Patient	Source	Resistance profile (^*)	Cabapenemases
Strain	Specie	Patient	Source	Resistance profile (^*)	Rapid Blue-Carba test	metallo-β-lactamases	KPC-MBL Kit
Kb846	K. pneumoniae	1	blood culture, catheter	AMP; SAM; TZP; CEP; CTX; CAZ; IMP; MEM; AMK; GEN; NAL; CIP; NIT; COL; TMS	Positive	negative	positive
Ps848	P. stuartii	1	blood culture	AMP; SAM; TZP; CEP; CTX; CAZ; IMP; MEM; GEN; NAL; CIP; NIT; COL; TMS	positive	positive	positive
PaC850	P. aeruginosa	1	urine culture	AMP; SAM; CEP; CTX; CAZ; IMP; NAL; CIP; NIT; FEP	positive	positive	positive
Ps850	P. stuartii	1	urine culture	AMP; SAM; TZP; CEP; CTX; CAZ; IMP; MEM; GEN; NAL; CIP; NIT; COL; FEP	positive	positive	positive
Ps722	P. stuartii	2	abscess culture	AMP; SAM; CEP; GEN; CTX; CAZ; IMP; MEM; NAL; NIT; COL; CIP	(indeterminate)	positive	positive
Pr783	P. rettgeri	3	surgical toilette	AMP; SAM; TZP; CEP; CTX; CAZ; IMP; MEM; NAL; NIT; COL; FEP; TMS	(indeterminate)	positive	positive
Pm856	P. mirabilis	4	urine culture	AMP; SAM; TZP; CEP; CTX; CAZ; IMP; MEM; NAL; NIT; COL; FEP; TMS; GEN; CIP	positive	positive	positive
Kb443	K. pneumoniae	5	tracheal aspirate	AMP; SAM; TZP; CEP; CTX; CAZ; IMP; MEM; NAL; AMK; TMS; GEN; CIP	positive	positive	positive

AMP: ampicillin; SAM: ampicillin-sulbactam; TZP: piperacillin-tazobactam; CEP: cefalotine; CTX: cefotaxime; CAZ: ceftazidime; IMP: imipenem; MEM: meropenem; AMK: amikacin; GEN: gentamycin; NAL: nalidixic acid; CIP: ciprofloxaxine; NIT: nitrofurantoin; COL: colistin; TMS: trimethoprim-sulfamethoxazole; FEP: cephepime;

^(*)

: Resistance profile only; Indeterminate: a color change was obtained after 2 hours of incubation